// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























7277 Abstracts

A Case Series of CML Patients Who Were Presented with Isolated Thrombocytosis

Volkan Karakus - American Society of Hematology (ASH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Omacetaxine mepesuccinate

TET2 Mutation Is More Valuable in Predicting Thrombosis in Thrombocythemia Patients Compared to Polycythaemia Vera

Ziqing Wang - American Society of Hematology (ASH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

The Clinical Profile of JAK2 Negative,Normal Erythropoeitin,Normal Arterial Oxygen Saturation Erythrocytosis in an Indian Tertiary Centre

Sreeraj Vasudevan - American Society of Hematology (ASH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Erythropoietin

Study of JAK2 V617F allele Burden By Droplet Digital PCR in BCR-ABL1 Negative Myeloproliferative Neoplasms and Its Implications on Disease Phenotype

Loomila L - American Society of Hematology (ASH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Ruxolitinib phosphate

Global Hemostatic Assays for Risk Stratification of Thrombosis in Myeloproliferative Neoplasms (MPN): A Systematic Review and Meta-Analysis

Andrew Chua Tiu - American Society of Hematology (ASH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Hemostatic Solution

Thrombosis in Tregs-Induced Thrombocithopenia in Patients with Myelofibrosis

Rossella Rosari Cacciola - American Society of Hematology (ASH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Epinephrine

Myeloproliferative Neoplasms in Three Governorates in Egypt: A Multicenter, Observational, Epidemiological Study

Mervat Mattar - American Society of Hematology (ASH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Hydroxyurea

How to Treat Isolated Leptomeningeal Relapse of Multiple Myeloma 11 Years after Autologous Stem Cell Transplantation (ASCT)

Eduardo E. Reynoso - American Society of Hematology (ASH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Hydrocortisone

Cell Product Differences on Incidence of Venous Thromboembolism in Patients Treated with CAR T-Cells for Aggressive B-Cell Lymphomas

Taylor Brooks - American Society of Hematology (ASH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Refining Clinical Risk Stratification for Estimating the Risk of Ischemic Stroke in Non-Atrial Fibrillation Patients with a Novel Risk Stratification Tool, CHA₂DS₂-Vasc + Score

Abinesh Sekar - American Society of Hematology (ASH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

A Retrospective Analysis of Thromboprophylaxis in Hospitalized Patients with Cancer

Alex Dipierdomenico - American Society of Hematology (ASH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Anything but Cookbook Medicine: Exploring the Influence of Supervisor Practice Variability on Resident Learning in Thrombosis Medicine

Shahzaib Khattak - American Society of Hematology (ASH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Use of JAK 2 v617f As a Hypercoagulable Test in a Community Hospital

Danny Landau - American Society of Hematology (ASH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Documentation of Menstrual Concerns in Patients with Inherited Bleeding Disorders

Ximena Tienhoven - American Society of Hematology (ASH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Values and Preferences Towards Antithrombotic Therapy in Patients with Myeloproliferative Neoplasms: A Qualitative Study

Jonah Rakoff - American Society of Hematology (ASH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

N/A

Routine Implementation of Magnetic Resonance Venography in Neonates with Encephalopathy Receiving Therapeutic Hypothermia and Its Value in the Diagnosis of Cerebral Venous Sinus Thrombosis

Chelsea Munster - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Safety Data After Implementation of a Pragmatic Trial Using a Predictive Model for Venous Thromboembolism (VTE) Prevention

Shannon C. Walker - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Copyright © 2026. QuantiNova All rights reserved